April 7, 2014 | Five former portfolio companies from the RAD BioMed accelerator have raised a total of $7 million in follow-on investments from the RAD Group and additional private investors. “Globes” reports that The companies are VGS Ltd., which has developed a method for reducing rejection of vein grafts; Vectorious Medical Technologies Ltd., which has developed an implant for early diagnosis of heart failure; Laminate Medical Technologies Ltd., which is developing an implant for improving renal vascular procedures; Perflow Medical Ltd., which is developing endovascular device for removing blood clots during brain surgery to prevent ischemic stroke; and Moebius Medical Ltd., which has developed liposomal lubricants for treating osteoarthritis.
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Facebook comments